Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
8.265 EUR | +0.61% | +3.05% | -1.90% |
Mar. 13 | Almirall Signs License Deal with Eloxx Pharmaceuticals for Skin Diseases Treatment | MT |
Feb. 19 | Global markets live: Apple, Nintendo, Super Micro Computer, Currys, ABB... |
Sales 2024 * | 972M 1.05B | Sales 2025 * | 1.07B 1.15B | Capitalization | 1.73B 1.86B |
---|---|---|---|---|---|
Net income 2024 * | 25M 26.94M | Net income 2025 * | 61M 65.73M | EV / Sales 2024 * | 1.68 x |
Net cash position 2024 * | 94.21M 102M | Net cash position 2025 * | 134M 145M | EV / Sales 2025 * | 1.49 x |
P/E ratio 2024 * |
80.4
x | P/E ratio 2025 * |
29.1
x | Employees | 1,904 |
Yield 2024 * |
2.26% | Yield 2025 * |
2.29% | Free-Float | 34.78% |
Latest transcript on Almirall, S.A.
1 day | +0.61% | ||
1 week | +3.05% | ||
Current month | +4.36% | ||
1 month | +1.35% | ||
3 months | -2.71% | ||
6 months | -13.23% | ||
Current year | -1.90% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 14-07-24 | |
Director of Finance/CFO | 54 | 19-11-10 | |
Karl Ziegelbauer
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 81 | 07-05-28 | |
Seth J. Orlow
BRD | Director/Board Member | - | 15-12-31 |
Eva-Lotta Allan
BRD | Director/Board Member | 65 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 735 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 36 M€ | +4.92% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 8.265 | +0.61% | 196,575 |
24-03-27 | 8.215 | +0.80% | 228,254 |
24-03-26 | 8.15 | +1.31% | 151,121 |
24-03-25 | 8.045 | +0.19% | 147,032 |
24-03-22 | 8.03 | +0.12% | 189,390 |
Delayed Quote BME, March 28, 2024 at 12:35 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.90% | 1.87B | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |